blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2514746

EP2514746 - Stable crystal of 4-oxoquinoline compound [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.01.2018
Database last updated on 14.06.2024
FormerGrant of patent is intended
Status updated on  20.04.2017
FormerExamination is in progress
Status updated on  29.03.2017
FormerGrant of patent is intended
Status updated on  12.01.2017
Most recent event   Tooltip26.01.2018Application deemed to be withdrawnpublished on 28.02.2018  [2018/09]
Applicant(s)For all designated states
Japan Tobacco Inc.
2-1, Toranomon 2-chome
Minato-ku
Tokyo 105-8422 / JP
[2015/46]
Former [2012/43]For all designated states
Japan Tobacco, Inc.
2-1, Toranomon 2-chome, Minato-ku
Tokyo 105-8422 / JP
Inventor(s)01 / Satoh, Motohide
c/o Central Pharmaceutical Research Institute
of Japan Tobacco, Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
02 / Motomura, Takahisa
c/o Central Pharmaceutical Research Institute
of Japan Tobacco, Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
03 / Matsuda, Takashi
c/o Central Pharmaceutical Research Institute
of Japan Tobacco, Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
04 / Kondo, Kentaro
c/o Central Pharmaceutical Research Institute
of Japan Tobacco, Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
05 / Ando, Koji
c/o Central Pharmaceutical Research Institute
of Japan Tobacco, Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
06 / Matsuda, Koji
c/o Central Pharmaceutical Research Institute
of Japan Tobacco, Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
07 / Miyake, Shuji
c/o Central Pharmaceutical Research Institute
of Japan Tobacco, Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
08 / Uehara, Hideto
c/o Central Pharmaceutical Research Institute
of Japan Tobacco, Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
[N/P]
Former [2013/02]01 / Satoh, Motohide
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
02 / Motomura, Takahisa
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
03 / Matsuda, Takashi
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
04 / Kondo, Kentaro
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
05 / Ando, Koji
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
06 / Matsuda, Koji
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
07 / Miake, Shuji
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
08 / Uehara, Hideto
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
Former [2012/49]01 / Motohide, Satoh
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
02 / Tkahisa, Motomura
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
03 / Takashi, Matsuda
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
04 / Kentaro, Kondo
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
05 / Koji, Ando
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
06 / Koji, Matsuda
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
07 / Shuji, Miyake
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
08 / Hideto, Uehara
c/o Central Pharmaceutical Research Institute
of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2012/43]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date12173572.419.05.2005
[2012/43]
Priority number, dateJP2004015097920.05.2004         Original published format: JP 2004150979
[2012/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2514746
Date:24.10.2012
Language:EN
[2012/43]
Search report(s)(Supplementary) European search report - dispatched on:EP26.09.2012
ClassificationIPC:C07D215/56, A61K31/47, A61P31/18
[2012/43]
CPC:
C07D215/56 (EP,KR,NO,US); A61K31/47 (KR,NO); A61P31/00 (EP);
A61P31/18 (EP,NO)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/43]
Extension statesAL23.04.2013
BA23.04.2013
HR23.04.2013
LV23.04.2013
MK23.04.2013
YU23.04.2013
TitleGerman:Stabiler Kristall einer 4-Oxochinolinverbindung[2012/43]
English:Stable crystal of 4-oxoquinoline compound[2012/43]
French:Cristal stable de composé 4-oxoquinoline[2012/43]
Examination procedure23.04.2013Examination requested  [2013/23]
29.07.2013Amendment by applicant (claims and/or description)
20.01.2014Despatch of a communication from the examining division (Time limit: M07)
02.12.2014Reply to a communication from the examining division
15.10.2015Communication of intention to grant the patent
16.06.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
01.08.2016Communication of intention to grant the patent
21.02.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
21.04.2017Communication of intention to grant the patent
02.09.2017Application deemed to be withdrawn, date of legal effect  [2018/09]
11.10.2017Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2018/09]
Parent application(s)   TooltipEP05726243.8  / EP1636190
Divisional application(s)EP17186674.2  / EP3281939
EP23203885.1
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
21.03.2017Request for further processing filed
21.03.2017Full payment received (date of receipt of payment)
Request granted
04.04.2017Decision despatched
The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
16.06.2016Request for further processing filed
16.06.2016Full payment received (date of receipt of payment)
Request granted
28.06.2016Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
02.12.2014Request for further processing filed
02.12.2014Full payment received (date of receipt of payment)
Request granted
18.12.2014Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
29.07.2013Request for further processing filed
29.07.2013Full payment received (date of receipt of payment)
Request granted
09.08.2013Decision despatched
Fees paidRenewal fee
24.10.2012Renewal fee patent year 03
24.10.2012Renewal fee patent year 04
24.10.2012Renewal fee patent year 05
24.10.2012Renewal fee patent year 06
24.10.2012Renewal fee patent year 07
24.10.2012Renewal fee patent year 08
24.05.2013Renewal fee patent year 09
17.03.2014Renewal fee patent year 10
20.05.2015Renewal fee patent year 11
30.03.2016Renewal fee patent year 12
27.07.2017Renewal fee patent year 13
Penalty fee
Additional fee for renewal fee
31.05.201713   M06   Fee paid on   27.07.2017
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US3472859  (LESHER GEORGE Y) [A] 1-12 * claim 1 *;
 [A]WO9845269  (CENTRE NAT RECH SCIENT [FR], et al) [A] 1-12 * claim 1 *;
 [E]EP1564210  (JAPAN TOBACCO INC [JP]) [E] 1-12* example 4-32 on page 18 *
by applicantJPH01511520C
 JPS6450979
 JP3567162B
    - J. VIROL., (1993), vol. 67, pages 425 - 437
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.